Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies. (Q53249666)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 September 2006

Language	Label	Description	Also known as
English	Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies.	scientific article published on 18 September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

author name string

Munker R

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Reibke R

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Kolb HJ

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

language of work or name

0 references

publication date

18 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

38

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

593-607

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

DNA fusion gene vaccines against cancer: from the laboratory to the clinic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Cloning of herpesviral genomes as bacterial artificial chromosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Mechanisms of B-cell lymphoma pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Determinants of antileukemia effects of allogeneic NK cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Graft-versus-leukemia reactions in allogeneic chimeras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

The fate of human Langerhans cells in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy for EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoimmunotherapy--towards real progress in the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705499

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53249666&oldid=2212046411"